Pacira Pharmaceuticals launches EXPAREL By: MarketMinute.com Stock News September 21, 2016 at 18:34 PM EDT Pacira Pharmaceuticals Inc. (Nasdaq: PCRX) launched EXPAREL to treat pain from a third molar extraction but the stock price tumbled $3.55 to close at $36.82. Related Stocks: Pacira Pharm Inc